DUX4 and facioscapulohumeral muscular dystrophy: In summary, we identified miR-675 as a natural DUX4 inhibitor that may have therapeutic applications for treating FSHD, and natural miR-675 variations among individual people could influence DUX4 expression, thereby justifying future examination of miR-675 as a potential disease modifier.